| Source: |
| Type: |
| Toxicity |
| 8513- | MAG, | Magnolia extract is effective for the chemoprevention of oral cancer through its ability to inhibit mitochondrial respiration at complex I |
| - | vitro+vivo, | Oral, | SCC4 | - | in-vitro, | Tong, | SCC9 | - | in-vitro, | SCC, | CAL27 |
| 8512- | MAG, | Enhanced Oral Bioavailability of the Pharmacologically Active Lignin Magnolol via Zr-Based Metal Organic Framework Impregnation |
| - | in-vivo, | Nor, | NA |
| - | vitro+vivo, | CRC, | HT-29 | - | in-vitro, | Colon, | CT26 |
| 8509- | MAG, | Rad, | The In Vivo Radiosensitizing Effect of Magnolol on Tumor Growth of Hepatocellular Carcinoma |
| - | in-vivo, | HCC, | NA |
| 4528- | MAG, | Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update |
| - | Review, | Nor, | NA |
| 4526- | MAG, | HNK, | Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis |
| - | Review, | Var, | NA |
| 4521- | MAG, | HNK, | Safety and Toxicology of Magnolol and Honokiol |
| - | Review, | Nor, | NA |
| 8567- | Matr, | Matrine induces apoptosis in multiple colorectal cancer cell lines in vitro and inhibits tumour growth with minimum side effects in vivo via Bcl-2 and caspase-3 |
| - | vitro+vivo, | CRC, | NA |
| 8535- | Matr, | Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel |
| - | in-vitro, | Cerv, | NA |
| 8559- | Matr, | Matrine induces toxicity in mouse liver cells through an ROS-dependent mechanism |
| - | vitro+vivo, | Nor, | NA |
| 8526- | Matr, | A Systematic Review of the Pharmacology, Toxicology and Pharmacokinetics of Matrine |
| - | Review, | Nor, | NA |
| 8555- | Matr, | Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review |
| - | Review, | Var, | NA |
| 8553- | Matr, | Research progress on the pharmacological effects of matrine |
| - | Review, | Nor, | NA |
| 8551- | Matr, | Research Progress of Natural Matrine Compounds and Synthetic Matrine Derivatives |
| - | Review, | Nor, | NA |
| 8549- | Matr, | Matrine disrupts Nrf2/GPX4 antioxidant system and promotes hepatocyte ferroptosis |
| - | in-vitro, | Var, | NA |
| 8548- | Matr, | The DHCR7 is the key target of lipotoxic liver injury caused by matrine through abnormal activation of the cholesterol synthesis pathway |
| - | in-vitro, | LiverDam, | NA |
| 8626- | MBZ, | The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells |
| - | in-vitro, | Lung, | NA |
| 8629- | MBZ, | Repurposing the antihelmintic mebendazole as a hedgehog inhibitor |
| - | in-vitro, | Nor, | NIH-3T3 | - | vitro+vivo, | GBM, | GL-15 | - | in-vitro, | GC, | DAOY |
| 8634- | MBZ, | Rad, | Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer |
| - | vitro+vivo, | BC, | MCF7 | - | in-vitro, | BC, | T47D | - | in-vitro, | BC, | MDA-MB-231 |
| 8637- | MBZ, | Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors |
| - | Trial, | MB, | NA |
| 8643- | MBZ, | Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | 4T1 | - | in-vitro, | BC, | SUM159 |
| 8652- | MBZ, | Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors |
| - | vitro+vivo, | GBM, | GL-15 |
| 2487- | mCHEMO, | Metronomic Chemotherapy: Possible Clinical Application in Advanced Hepatocellular Carcinoma |
| - | Review, | HCC, | NA |
| 2488- | mCHEMO, | Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma |
| - | in-vitro, | HCC, | HUH7 | - | in-vivo, | HCC, | NA |
| 8796- | mCHEMO, | Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma |
| - | Study, | NPC, | NA |
| 8795- | mCHEMO, | Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study |
| - | Trial, | NPC, | NA |
| 8793- | mCHEMO, | Metronomic Chemotherapy in Breast Cancer as a Strategy to Deliver More Sustainable and Less Toxic Treatments: Time to Debunk the Myth? |
| - | Review, | Var, | NA |
| 8785- | mCHEMO, | capec, | Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
| - | Trial, | NPC, | NA |
| 8786- | mCHEMO, | Metronomic chemotherapy in cancer treatment: new wine in an old bottle |
| - | Review, | Var, | NA |
| 8787- | mCHEMO, | Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy |
| - | Review, | Var, | NA |
| 8788- | mCHEMO, | Metronomic Chemotherapy: A Novel Approach in Cancer Treatment |
| - | Review, | Var, | NA |
| 8794- | mCHEMO, | Metronomic chemotherapy and breast cancer: a critical evaluation of its role in the new landscape of therapeutics |
| - | Review, | BC, | NA |
| - | Trial, | Pca, | NA |
| 8814- | MCP, | Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study |
| - | Trial, | Pca, | NA |
| 8824- | MCP, | Clinical Benefit in Patients with Advanced Solid Tumors Treated with Modified Citrus Pectin: A Prospective Pilot Study |
| - | Trial, | Var, | NA |
| 8620- | MCT, | Medium-Chain Triglycerides: Scientific and Regulatory Perspectives from Germany and Japan with a US Context—A Concise Review |
| - | Review, | Nor, | NA |
| 3905- | MCT, | Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies |
| - | Review, | AD, | NA |
| 1898- | MeJa, | Methyl jasmonate and its potential in cancer therapy |
| - | Review, | Var, | NA |
| 6541- | MeSal, | Toxicology Answer: Oil of Wintergreen |
| - | Review, | Nor, | NA |
| 8707- | MET, | Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 8705- | MET, | Clinical pharmacokinetics of metformin |
| - | Review, | Nor, | NA |
| 2456- | MET, | Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vivo, | NA, | NA |
| 5785- | MET, | Metformin improves healthspan and lifespan in mice |
| - | in-vivo, | Nor, | NA |
| 5795- | MET, | Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Diabetic, | NA |
| 5800- | MET, | Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect |
| - | Review, | Var, | NA |
| 2260- | MF, | Alternative magnetic field exposure suppresses tumor growth via metabolic reprogramming |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | LN229 | - | in-vivo, | NA, | NA |
| 3457- | MF, | Cellular stress response to extremely low‐frequency electromagnetic fields (ELF‐EMF): An explanation for controversial effects of ELF‐EMF on apoptosis |
| - | Review, | Var, | NA |
| 3475- | MF, | A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by Modulating the Endocannabinoid System in HT22 Cells |
| - | in-vitro, | Nor, | HT22 | - | Review, | AD, | NA |
| 3566- | MF, | Positive and Negative Effects of Administering a Magnetic Field to Patients with Rheumatoid Arthritis (RA) |
| - | Study, | Arthritis, | NA |
| 3536- | MF, | Targeting Mesenchymal Stromal Cells/Pericytes (MSCs) With Pulsed Electromagnetic Field (PEMF) Has the Potential to Treat Rheumatoid Arthritis |
| - | Review, | Arthritis, | NA | - | Review, | Stroke, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1025 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid